1. "2017"
  2. "Elsevier Inc."
  3. "Breast Medicine Service"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (5)
Groups
  1. Breast Medicine Service (13)
  2. Department of Medicine (13)
  3. Solid Tumor Oncology Division (13)
  4. Survivorship Research (8)
  5. Biostatistics Service (4)
  6. Epidemiology and Biostatistics (4)

More Groups

People
  1. Clifford Hudis (4)
  2. Sujata Patil (3)
  3. Andrew Seidman (2)
  4. Larry Norton (2)
  5. Mark Robson (2)
  6. Molly Wilgucki (2)

More People

Years
  1. 2017 (13)
Publications
  1. Breast (3)
  2. Clinical Breast Cancer (3)
  3. International Journal of Radiation Oncology, Biology, Physics (2)
  4. Clinical Lymphoma, Myeloma and Leukemia (1)
  5. European Journal of Cancer (1)
  6. Gynecologic Oncology (1)

More Publications

Publishers
  1. Elsevier Inc. (13)

Results (13)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • RESILIENCE: Phase III randomized, double-blind trial comparing sorafenib with capecitabine versus placebo with capecitabine in locally advanced or metastatic HER2-negative breast cancer
    Journal Article

    Baselga, J.; Zamagni, C.; Gómez, P.; Bermejo, B.; Nagai, S. E.; Melichar, B.; Chan, A.; Mángel, L.; Bergh, J.; Costa, F.; more...
    Clinical Breast Cancer (2017)

    Fulltext@MSK | Save
  • Quantifying the incidence of homologous recombination repair status in metastatic triple negative breast cancer receiving concurrent cisplatin and radiation therapy
    Meeting Abstract

    Powell, S. N.; Gucalp, A.; Traina, T. A.; Patil, S.; Wilgucki, M.; Arnold, B. B.; Cahlon, O.; Delsite, R.; Ulaner, G. A.; Ho, A. Y.
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Triplet combination of endocrine therapy with CDK 4/6 inhibitor, ribociclib, and MTOR inhibitor, everolimus in HR+, HER2-ABC: Results from the dose-expansion cohort
    Meeting Abstract

    Bardia, A.; Cortés, J.; Modi, S.; Oliveira, M.; Campone, M.; Ma, B.; Dirix, L.; Weise, A.; Kittaneh, M.; Hewes, B.; more...
    Breast (2017)

    Fulltext@MSK | Save
  • Prevalence and impact of variants of uncertain significance on local therapy decision-making in newly diagnosed breast cancer patients
    Meeting Abstract

    Ho, A. Y.; Amoroso, K.; Wilgucki, M.; Vora, K.; Arnold, B. B.; Powell, S. N.; Morrow, M.; Robson, M. E.
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology white paper
    Journal Article

    Randall, L. M.; Pothuri, B.; Swisher, E. M.; Diaz, J. P.; Buchanan, A.; Witkop, C. T.; Bethan Powell, C.; Smith, E. B.; Robson, M. E.; Boyd, J.; more...
    Gynecologic Oncology (2017)

    Fulltext@MSK | Save
  • Defining progression free survival after multiple lines of therapy and impact of dynamic changes in FLIPI for multiply relapsed follicular lymphoma in the rituximab era treated at Memorial Sloan Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Alperovich, A.; Batlevi, C.; Smith, K.; Ying, Z.; Caron, P.; Drullinsky, P.; Gerecitano, J.; Hamilton, A.; Hamlin, P.; Horwitz, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Assessing fracture risk in early stage breast cancer patients treated with aromatase-inhibitors: An enhanced screening approach incorporating trabecular bone score
    Journal Article

    Mariotti, V.; Page, D. B.; Davydov, O.; Hans, D.; Hudis, C. A.; Patil, S.; Kunte, S.; Girotra, M.; Farooki, A.; Fornier, M. N.
    Journal of Bone Oncology (2017)

    Fulltext@MSK | Save
  • A summary of head-to-head comparisons of patient (pt) risk classifications by the 21-gene Recurrence Score (R) (RS) assay and other genomic assays for early breast cancer (EBC)
    Meeting Abstract

    Varga, Z.; McCullough, D.; Lau, A.; Stoppler, M.; Baehner, F. L.; Seidman, A. D.
    Breast (2017)

    Fulltext@MSK | Save
  • A Phase 1/2 trial of ruxolitinib and erlotinib in patients with EGFR-mutant lung adenocarcinomas with acquired resistance to erlotinib
    Journal Article

    Yu, H. A.; Perez, L.; Chang, Q.; Gao, S. P.; Kris, M. G.; Riely, G. J.; Bromberg, J.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • The role of bevacizumab in solid tumours: A literature based meta-analysis of randomised trials
    Journal Article

    Roviello, G.; Bachelot, T.; Hudis, C. A.; Curigliano, G.; Reynolds, A. R.; Petrioli, R.; Generali, D.
    European Journal of Cancer (2017)

    Fulltext@MSK | Save